
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Revenue | $251.5M | $153.8M | $142.1M | $119M | $125.6M | |
Revenue Growth (YoY) | 3.36% | -38.83% | -7.66% | -16.21% | 5.49% | |
Cost of Revenues | $54.8M | $49.1M | $49.5M | $25M | $25.3M | |
Gross Profit | $196.7M | $104.8M | $92.5M | $94M | $100.2M | |
Gross Profit Margin | 78.2% | 68.1% | 65.13% | 78.98% | 79.81% | |
R&D Expenses | $47.8M | $38M | $41.3M | $51.2M | $43.4M | |
Selling, General & Admin | $128.8M | $105.3M | $109.1M | $92M | $71.2M | |
Other Inc / (Exp) | -- | -- | -- | -- | -- | |
Operating Expenses | $174.2M | $141M | $139.1M | $134.8M | $113.8M | |
Operating Income | $22.5M | -$36.2M | -$46.6M | -$40.8M | -$13.6M | |
Net Interest Expenses | $1.3M | $1.2M | $843.7K | -- | $378.8K | |
EBT. Incl. Unusual Items | $18.8M | -$36M | -$46.6M | -$38.1M | -$11.1M | |
Earnings of Discontinued Ops. | -- | $45.1M | $494.1M | -$8.5M | -$31.2M | |
Income Tax Expense | $4.1M | -$5.9M | -$6.3M | -$3.3M | -$1.2M | |
Net Income to Company | $14.7M | $15M | $453.8M | -$43.3M | -$41.1M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | $14.7M | $15M | $453.8M | -$43.3M | -$41.1M | |
Basic EPS (Cont. Ops) | $0.09 | $0.08 | $2.58 | -$0.25 | -$0.24 | |
Diluted EPS (Cont. Ops) | $0.09 | $0.08 | $2.58 | -$0.25 | -$0.24 | |
Weighted Average Basic Share | $158.1M | $158.4M | $171.3M | $175.6M | $176M | |
Weighted Average Diluted Share | $158.1M | $158.4M | $171.3M | $175.6M | $176M | |
EBITDA | $38.1M | -$17.3M | -$32.2M | -$17M | $33.8M | |
EBIT | $19.8M | -$35.2M | -$45.9M | -$37.4M | -$10.2M | |
Revenue (Reported) | $251.5M | $153.8M | $142.1M | $119M | $125.6M | |
Operating Income (Reported) | $22.5M | -$36.2M | -$46.6M | -$40.8M | -$13.6M | |
Operating Income (Adjusted) | $19.8M | -$35.2M | -$45.9M | -$37.4M | -$10.2M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $38M | $36.3M | $37.8M | $31.3M | $31.7M | |
Revenue Growth (YoY) | -37.23% | -4.35% | 4.21% | -17.27% | 1.16% | |
Cost of Revenues | $12.2M | $12.4M | $11.6M | $6.4M | $6M | |
Gross Profit | $25.8M | $23.9M | $26.2M | $24.9M | $25.6M | |
Gross Profit Margin | 67.94% | 65.85% | 69.34% | 79.45% | 80.97% | |
R&D Expenses | $8.8M | $10.2M | $14.1M | $11.3M | $9.8M | |
Selling, General & Admin | $24.9M | $30.5M | $30.1M | $17.2M | $17.4M | |
Other Inc / (Exp) | -- | -- | -- | -- | -- | |
Operating Expenses | $33.3M | $40.2M | $41.2M | $28M | $27.2M | |
Operating Income | -$7.5M | -$16.3M | -$15M | -$3.1M | -$1.5M | |
Net Interest Expenses | -- | $362.4K | -- | -- | $800.7K | |
EBT. Incl. Unusual Items | -$7.2M | -$16.7M | -$15M | -$2.4M | -$2.3M | |
Earnings of Discontinued Ops. | $12.1M | $10.5M | -- | -$432.3K | -$2.3M | |
Income Tax Expense | -$1.1M | -$2.1M | -$3.1M | -$530.1K | -$898.6K | |
Net Income to Company | $5.9M | -$4.1M | -$11.9M | -$2.3M | -$3.8M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | $5.9M | -$4.1M | -$11.9M | -$2.3M | -$3.8M | |
Basic EPS (Cont. Ops) | $0.04 | -$0.02 | -$0.06 | -$0.01 | -$0.02 | |
Diluted EPS (Cont. Ops) | $0.04 | -$0.02 | -$0.06 | -$0.01 | -$0.02 | |
Weighted Average Basic Share | $163.3M | $182.7M | $184.8M | $216.1M | $176.1M | |
Weighted Average Diluted Share | $163.3M | $182.7M | $184.8M | $216.1M | $176.1M | |
EBITDA | -$7.5M | -$12.3M | -$11.6M | $152.1K | $1.4M | |
EBIT | -$7.5M | -$16.3M | -$15M | -$3.1M | -$1.5M | |
Revenue (Reported) | $38M | $36.3M | $37.8M | $31.3M | $31.7M | |
Operating Income (Reported) | -$7.5M | -$16.3M | -$15M | -$3.1M | -$1.5M | |
Operating Income (Adjusted) | -$7.5M | -$16.3M | -$15M | -$3.1M | -$1.5M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $229.1M | $152.1M | $143.4M | $137.3M | $142.9M | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $53.3M | $49.3M | $48.7M | $35.9M | $34.3M | |
Gross Profit | $175.8M | $102.8M | $94.7M | $101.4M | $108.6M | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | $45.2M | $39.2M | $45M | $48.2M | $42M | |
Selling, General & Admin | $122.1M | $110.8M | $108.8M | $98.6M | $96.1M | |
Other Inc / (Exp) | -- | -- | -- | -- | -- | |
Operating Expenses | $165M | $147.8M | $140.5M | $137.4M | $135.3M | |
Operating Income | $10.8M | -$45M | -$45.8M | -$36M | -$26.7M | |
Net Interest Expenses | -- | $1.8M | $483.2K | -- | $1.5M | |
EBT. Incl. Unusual Items | $9M | -$45.4M | -$45.4M | -$36.4M | -$28.2M | |
Earnings of Discontinued Ops. | $12.1M | $43.7M | $489.1M | $1.5M | -$16.3M | |
Income Tax Expense | $2.7M | -$6.9M | -$7.4M | -$1.2M | -$1.8M | |
Net Income to Company | $18.3M | $5M | $446M | -$33.8M | -$42.5M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | $18.4M | $5.1M | $451M | -$33.7M | -$42.6M | |
Basic EPS (Cont. Ops) | $0.11 | $0.03 | $2.57 | -$0.20 | -$0.24 | |
Diluted EPS (Cont. Ops) | $0.11 | $0.03 | $2.57 | -$0.20 | -$0.24 | |
Weighted Average Basic Share | ||||||
Weighted Average Diluted Share | ||||||
EBITDA | $8.1M | -$26.4M | -$32M | -$15.7M | $17.1M | |
EBIT | $8.1M | -$44M | -$45.1M | -$36M | -$26.7M | |
Revenue (Reported) | $229.1M | $152.1M | $143.4M | $137.3M | $142.9M | |
Operating Income (Reported) | $10.8M | -$45M | -$45.8M | -$36M | -$26.7M | |
Operating Income (Adjusted) | $8.1M | -$44M | -$45.1M | -$36M | -$26.7M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $38M | $36.3M | $37.8M | $31.3M | $31.7M | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $12.2M | $12.4M | $11.6M | $6.4M | $6M | |
Gross Profit | $25.8M | $23.9M | $26.2M | $24.9M | $25.6M | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | $8.8M | $10.2M | $14.1M | $11.3M | $9.8M | |
Selling, General & Admin | $24.9M | $30.5M | $30.1M | $17.2M | $17.4M | |
Other Inc / (Exp) | -- | -- | -- | -- | -- | |
Operating Expenses | $33.3M | $40.2M | $41.2M | $28M | $27.2M | |
Operating Income | -$7.5M | -$16.3M | -$15M | -$3.1M | -$1.5M | |
Net Interest Expenses | -- | $362.4K | -- | -- | $800.7K | |
EBT. Incl. Unusual Items | -$7.2M | -$16.7M | -$15M | -$2.4M | -$2.3M | |
Earnings of Discontinued Ops. | $12.1M | $10.5M | -- | -$432.3K | -$2.3M | |
Income Tax Expense | -$1.1M | -$2.1M | -$3.1M | -$530.1K | -$898.6K | |
Net Income to Company | $5.9M | -$4.1M | -$11.9M | -$2.3M | -$3.8M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | $5.9M | -$4.1M | -$11.9M | -$2.3M | -$3.8M | |
Basic EPS (Cont. Ops) | $0.04 | -$0.02 | -$0.06 | -$0.01 | -$0.02 | |
Diluted EPS (Cont. Ops) | $0.04 | -$0.02 | -$0.06 | -$0.01 | -$0.02 | |
Weighted Average Basic Share | $163.3M | $182.7M | $184.8M | $216.1M | $176.1M | |
Weighted Average Diluted Share | $163.3M | $182.7M | $184.8M | $216.1M | $176.1M | |
EBITDA | -$7.5M | -$12.3M | -$11.6M | $152.1K | $1.4M | |
EBIT | -$7.5M | -$16.3M | -$15M | -$3.1M | -$1.5M | |
Revenue (Reported) | $38M | $36.3M | $37.8M | $31.3M | $31.7M | |
Operating Income (Reported) | -$7.5M | -$16.3M | -$15M | -$3.1M | -$1.5M | |
Operating Income (Adjusted) | -$7.5M | -$16.3M | -$15M | -$3.1M | -$1.5M |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $63.2M | $59.9M | $59.1M | $40.5M | $28.4M | |
Short Term Investments | $75K | $69.1K | $15M | $28.7K | $27.1K | |
Accounts Receivable, Net | $46.8M | $43.3M | $28.3M | $25.6M | $19.5M | |
Inventory | $91K | $57.7K | -- | -- | -- | |
Prepaid Expenses | $9.7M | $10.6M | $7.8M | $6.1M | $5.4M | |
Other Current Assets | -- | $40.8K | $255.2K | -- | -- | |
Total Current Assets | $127M | $123.8M | $120.8M | $83M | $94.6M | |
Property Plant And Equipment | $17.3M | $13.6M | $11.4M | $14.7M | $25M | |
Long-Term Investments | -- | -- | -- | -- | -- | |
Goodwill | $100.8M | $96.4M | $89M | $86.3M | $37.3M | |
Other Intangibles | $41.8M | $38.2M | $25.3M | $22.8M | $17.4M | |
Other Long-Term Assets | -$1.2K | $4.5K | $37.5K | -$421.2K | -$2.1K | |
Total Assets | $292.5M | $278.8M | $263.6M | $229.3M | $192.3M | |
Accounts Payable | $5.1M | $6.8M | $4.7M | $19.9M | $3.6M | |
Accrued Expenses | -- | -- | -- | -- | -- | |
Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
Other Current Liabilities | $11.5M | $7.7M | $6M | $51M | $39M | |
Total Current Liabilities | $129M | $119M | $78.6M | $81.4M | $67.1M | |
Long-Term Debt | -- | -- | -- | -- | -- | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $191.2M | $170.8M | $113.4M | $115.4M | $120.3M | |
Common Stock | $1.9M | $1.8M | $85.8K | $88.4K | $83.3K | |
Other Common Equity Adj | -- | -- | -- | -- | -- | |
Common Equity | $101.3M | $108M | $150.2M | $113.8M | $72M | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -- | -- | -- | -- | -- | |
Total Equity | $101.3M | $108M | $150.2M | $113.8M | $72M | |
Total Liabilities and Equity | $292.5M | $278.8M | $263.6M | $229.3M | $192.3M | |
Cash and Short Terms | $63.3M | $60M | $74.1M | $40.5M | $28.4M | |
Total Debt | $49M | $32.2M | $14.2M | $15.2M | $27.8M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $55.2M | $124.2M | $37.6M | $34.9M | $24.6M | |
Short Term Investments | $117.2K | -- | $28M | $28.1K | $23.8K | |
Accounts Receivable, Net | $61.7M | $37.6M | $35.7M | $36.2M | $27.9M | |
Inventory | $117.2K | -- | -- | -- | -- | |
Prepaid Expenses | -- | -- | -- | -- | -- | |
Other Current Assets | -- | -- | $1.1K | $1.1K | -- | |
Total Current Assets | $121.9M | $211.8M | $113.7M | $81.8M | $93.8M | |
Property Plant And Equipment | $16.8M | $14.1M | $12.3M | $13.6M | $25.3M | |
Long-Term Investments | -- | -- | -- | -- | -- | |
Goodwill | $100.3M | $95.9M | $91.1M | $88M | $38.6M | |
Other Intangibles | $40.2M | $30M | $24.9M | $18.4M | $17.1M | |
Other Long-Term Assets | -- | -- | -- | -- | -$1.1K | |
Total Assets | $284.3M | $358.6M | $258.6M | $220.7M | $194.3M | |
Accounts Payable | $37.2M | $24.8M | $17.5M | $17.5M | $12.1M | |
Accrued Expenses | -- | -- | -- | -- | -- | |
Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
Current Portion Of Capital Lease Obligations | $5M | -- | -- | -- | -- | |
Other Current Liabilities | -- | -$111.6K | -- | $1.1K | -- | |
Total Current Liabilities | $121.7M | $116.9M | $82.1M | $75.7M | $77.2M | |
Long-Term Debt | $22.3M | -- | -- | -- | -- | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $183.8M | $167.5M | $116M | $110.9M | $122.4M | |
Common Stock | $1.9M | $1.8M | $87.2K | $86.4K | $86.6K | |
Other Common Equity Adj | -- | -- | -- | -- | -- | |
Common Equity | -- | -- | -- | -- | -- | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -- | -- | -- | -- | -- | |
Total Equity | $100.5M | $191.1M | $142.6M | $109.8M | $71.9M | |
Total Liabilities and Equity | $284.3M | $358.6M | $258.6M | $220.7M | $194.3M | |
Cash and Short Terms | $55.3M | $124.2M | $65.7M | $34.9M | $24.6M | |
Total Debt | $29.4M | $33M | $14.3M | $14.2M | $29M |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $14.7M | $15M | $453.8M | -$43.3M | -$41.1M | |
Depreciation & Amoritzation | $18.3M | $17.8M | $13.7M | $20.4M | $44M | |
Stock-Based Compensation | -- | -- | -- | -- | -- | |
Change in Accounts Receivable | $7M | -$4.9M | -$9.4M | $5M | $2.1M | |
Change in Inventories | $37.7K | $27.2K | $6.3K | -- | -- | |
Cash From Operations | $53.3M | $36.4M | -$21.3M | -$25M | $663.5K | |
Capital Expenditures | $9.3M | $7.8M | $5M | $5.6M | $6.4M | |
Cash Acquisitions | -$4.2M | -- | -$774.1K | $1.7M | $2.5M | |
Cash From Investing | -$13.2M | -$7.3M | -$20.5M | $12.2M | -$3.9M | |
Dividends Paid (Ex Special Dividend) | -- | -$7.5M | -- | -- | -- | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | $11.4M | -- | -- | -- | -- | |
Long-Term Debt Repaid | -$12.6M | -$13M | -$20M | -- | -- | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -- | -$1.2K | -- | -- | -- | |
Cash From Financing | -$9.4M | -$27.6M | $53.8M | -$6.6M | -$7M | |
Beginning Cash (CF) | $29M | $60.8M | $55.8M | $59.7M | $39.6M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $30.7M | $1.5M | $11.9M | -$19.4M | -$10.2M | |
Ending Cash (CF) | $58.7M | $62.6M | $58.1M | $39.6M | $29.5M | |
Levered Free Cash Flow | $44M | $28.6M | -$26.4M | -$30.6M | -$5.8M |
Period Ending | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | 2025-06-30 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $1.7M | -$15M | -$7.7M | -$3.9M | -- | |
Depreciation & Amoritzation | $8.4M | $2.6M | $10.8M | $3.2M | -- | |
Stock-Based Compensation | -- | -- | -- | -- | -- | |
Change in Accounts Receivable | -- | -- | -- | -- | -- | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | $12.3M | -$12.4M | -$9.5M | -$3.5M | -- | |
Capital Expenditures | $2.4M | $2.2M | $2.2M | $1.6M | -- | |
Cash Acquisitions | -- | $2M | $11.4K | $210.9K | -- | |
Cash From Investing | -$2.4M | -$5.3M | $5M | -$1.4M | -- | |
Dividends Paid (Ex Special Dividend) | -$7.6M | -- | -- | -- | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -$3.6M | -- | -- | -- | -- | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -$120.5K | -- | -- | -$64.1K | -- | |
Cash From Financing | -$13.1M | -$86.6M | -$1.7M | -$2M | -- | |
Beginning Cash (CF) | $56.8M | $136.4M | $37M | $35.1M | -- | |
Foreign Exchange Rate Adjustment | -$120.5K | -$732.3K | -$395.6K | -$218K | -- | |
Additions / Reductions | -$3.3M | -$104.3M | -$6.2M | -$6.9M | -- | |
Ending Cash (CF) | $53.4M | $30.7M | $31.4M | $27.6M | -- | |
Levered Free Cash Flow | $9.9M | -$14.6M | -$11.6M | -$5.1M | -- |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $18.3M | $5M | $446M | -$33.8M | -$42.5M | |
Depreciation & Amoritzation | -- | $21.9M | $13.1M | $20.2M | $43.7M | |
Stock-Based Compensation | -- | -- | -- | -- | -- | |
Change in Accounts Receivable | -- | -- | -- | -- | -- | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | $48.4M | $28.4M | -$24.7M | -$20.4M | -$118.8K | |
Capital Expenditures | $8.1M | $7.5M | $5.1M | $5.7M | $5.4M | |
Cash Acquisitions | -$120.7K | -$1.3M | $1.3M | $2M | $1.5M | |
Cash From Investing | -$8M | -$8.3M | -$31.1M | $24.8M | -$3.8M | |
Dividends Paid (Ex Special Dividend) | -- | -$7.5M | -- | -- | -- | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -$18.6M | -- | -- | -- | -- | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -- | -- | -- | -- | -- | |
Cash From Financing | -$15.6M | $63.6M | -$31.2M | -$6.4M | -$6.4M | |
Beginning Cash (CF) | -- | -- | -- | -- | -- | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $24.8M | $83.7M | -$86.9M | -$2.1M | -$10.4M | |
Ending Cash (CF) | -- | -- | -- | -- | -- | |
Levered Free Cash Flow | $40.3M | $20.8M | -$29.8M | -$26.1M | -$5.5M |
Period Ending | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | 2025-06-30 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $7.6M | -$19.1M | -$19.6M | -$6.2M | -$3.8M | |
Depreciation & Amoritzation | $8.4M | $6.7M | $14.2M | $6.5M | $3M | |
Stock-Based Compensation | -- | -- | -- | -- | -- | |
Change in Accounts Receivable | -- | -- | -- | -- | -- | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | $16.6M | -$16.1M | -$16.4M | -$6M | -$3.2M | |
Capital Expenditures | $4.1M | $3.6M | $3.7M | $3.3M | $630.3K | |
Cash Acquisitions | -- | $742.4K | $760K | $1.2M | -- | |
Cash From Investing | -$4.1M | -$8.1M | -$8.2M | -$2.1M | -$626.1K | |
Dividends Paid (Ex Special Dividend) | -$7.6M | -- | -- | -- | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -$9.6M | -- | -- | -- | -- | |
Repurchase of Common Stock | -- | -- | -- | -- | -$211.5K | |
Other Financing Activities | -$120.5K | -- | -- | -- | -- | |
Cash From Financing | -$21M | -$3.2M | -$3.3M | -$3.4M | -$849.2K | |
Beginning Cash (CF) | $118.7M | $195.8M | $96.3M | $74.9M | $28.7M | |
Foreign Exchange Rate Adjustment | -- | -$722.2K | -$739.3K | -$410.3K | -$144.2K | |
Additions / Reductions | -$8.4M | -$27.3M | -$28M | -$11.4M | -$4.7M | |
Ending Cash (CF) | $110.1M | $167M | $68.4M | $62.7M | $23.9M | |
Levered Free Cash Flow | $12.5M | -$19.7M | -$20.2M | -$9.2M | -$3.8M |
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.